Yue Hu

Dr. Yue Hu


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 May 2018 in Oncology Letters
Verified
Journal Article
Closed access
PDF file
SWShengchao Wang
Shengchao Wang
YHYue Hu
Yue Hu
Lung cancer has one of the highest mortality rates among malignancies globally, and smoking has been documented as the main cause of lung cancer. Nicotinic acetylcholine receptors (nAChRs) were initially identified as notable regulators of the nervous system. In addition to their function in the brain, accumulating evidence indicates that nAChRs perform a host of diverse functions in almost all non‑neuronal mammalian cells. The homomeric α7nAChR, a subtype of nAChRs, is responsible for the proliferative, pro‑angiogenic and pro‑metastatic effects of nicotine in lung cancer. Provided the association of cigarette smoking with several disease types such as cardiovascular disease, the α7nAChR‑mediated signaling pathway has been implicated in the pathophysiology of lung cancer. Currently, strategies that target the α7nAChR including α7nAChR antagonists are considered to be potentially useful anticancer drugs for therapeutic purposes. Thus, the present review assesses current understanding of the function and underlying molecular mechanisms of α7nAChR in lung cancer and evaluates how targeting α7nAChR may result in novel therapeutic methods.

5 December 2022 in Cell Death Discovery
Verified
Journal Article
Open access
PDF file
YHYue Hu
Yue Hu
JSJing Shao
Jing Shao
LSLanying Shen
Lanying Shen
SWShengchao Wang
Shengchao Wang
KXKaiyan Xu
Kaiyan Xu
WCWei Chen
Wei Chen
Previous studies suggest that mesenchymal stem cells may represent a promising cellular therapy for acute lung injury (ALI); however, the underlying relevant molecular mechanisms remain unclear. Adipose-derived mesenchymal stem cells (ADSCs) were isolated and characterized by alizarin red staining, oil red staining, and flow cytometry. Lung injury and inflammatory cell infiltration were determined using the Evans blue method, wet/dry weight ratio, and H&E staining. An ELISA was used to detect the concentrations of IFN-γ, IL-2, and TNF-α. Autophagy was detected with an mRFP-GFP-LC3 dual-fluorescence autophagy indicator system, Western blotting, and electron microscopy. We first demonstrated that ADSCs did alleviate the inflammatory responses and tissue damage in lipopolysaccharide (LPS)-induced ALI. Next, we further demonstrated in vivo that autophagy plays a key role in the maintenance of ADSC therapeutic efficacy. In vitro experiments demonstrated that ADSCs co-cultured with alveolar epithelial cells depend on autophagy for significant anti-inflammatory functions. Moreover, the mammalian target of rapamycin (mTOR) is a key regulator of autophagy. Taken together, our findings demonstrate that the effect of ADSC on ALI, especially on alveolar epithelial cells, is dependent on mTOR-mediated autophagy maintenance. The significance of our study for ALI therapy is discussed with respect to a more complete understanding of the therapeutic strategy paradigm.

14 April 2023 in BMC Pulmonary Medicine
Verified
Journal Article
Open access
PDF file
YHYue Hu
Yue Hu
CLCuixia Liu
Cuixia Liu
SJShaojun Jin
Shaojun Jin
ZYZihan Yi
Zihan Yi
CWChao Wang
Chao Wang
HHHuaqiong Huang
Huaqiong Huang
Background: Immune checkpoint inhibitors (ICIs) have been widely used in the treatment of cancer. Moreover, immune-related adverse events (irAEs) have become a new clinical challenge. ICI-associated myocarditis is a rare but fatal condition among diverse organ injuries, and early recognition and effective interventions are critical for patients. Case presentation: In this report, we present the case of a healthy 60-year-old male who was diagnosed with lung squamous cell carcinomas following chemotherapy and received ICIs. The patient presented with asymptomatic cardiac biomarker elevation followed by immune-related myocarditis. Fortunately, the patient achieved a good clinical result after receiving high-dose steroids. The treatment with ICIs was discontinued because of recurrent increases in troponin T. Conclusion: ICI-mediated associated myocarditis is an uncommon but potentially life-threatening adverse event. The current data suggest that clinicians need to be cautious about reinitiation in low-grade patients; however, further study of the diagnosis and treatment is necessary.

2 September 2025 in Microbiology Spectrum
Verified
Journal Article
Open access
YJYe Jin
Ye Jin
ZYZihan Yi
Zihan Yi
YHYue Hu
Yue Hu
MHMan Huang
Man Huang
Enterococcal bloodstream infections (BSIs) in critically ill patients are linked to multidrug resistance (MDR), high morbidity, and increased mortality. We conducted a retrospective cohort study over a decade at a 3,500-bed teaching hospital, including intensive care unit patients diagnosed with enterococcal BSIs. Data on demographics, comorbidities, severity scores, treatments, and microbiological profiles were analyzed. Risk factors for infection and mortality were assessed using multivariate logistic regression. Among 101 patients, Enterococcus faecium was the predominant species, with nearly half of these isolates exhibiting MDR, particularly to ampicillin, aminoglycosides, and fluoroquinolones. Primary infection sources among all patients included abdominal (58.4%), catheter-related (32.7%), and wound infections (10.9%). Key mortality risk factors included a high Charlson comorbidity index (CCI ≥ 5; hazard ratio [HR] = 18.18, P < 0.001), male sex (HR = 3.09, P = 0.0174), prolonged hospitalization, mechanical ventilation >7 days, central venous catheter (CVC) use, prior broad-spectrum antibiotic exposure, immunosuppression, and delayed antimicrobial therapy (>24 hours; HR = 11.11, P < 0.001). Prior fluoroquinolone exposure and inadequate source control also increased mortality risk. In contrast, early source control (HR = 0.08, P < 0.001), timely targeted therapy (HR = 0.09, P = 0.00214), and early CVC removal (HR = 0.01, P < 0.001) improved survival. Persistent bacteremia and inflammatory markers were not independent mortality predictors. Future research should optimize antibiotic duration, refine risk prediction models, and develop novel therapies for MDR Enterococcus infections. IMPORTANCE: Enterococcal bloodstream infections are a serious concern in critically ill patients, often associated with multidrug resistance (MDR) and high mortality rates. This study highlights the importance of early intervention, including source control and timely antimicrobial therapy, in improving patient outcomes. By identifying key risk factors for mortality, such as comorbidities, male sex, and delayed treatment, this research provides valuable insights for clinicians in managing these infections. Notably, the study emphasizes the crucial role of early removal of central venous catheters and targeted therapy in reducing mortality risk. These findings underscore the need for effective infection prevention strategies and timely clinical decisions in critically ill patients. This work lays the foundation for future research aimed at optimizing treatment approaches and combating the growing challenge of MDR Enterococcus infections in intensive care settings.

1 April 2025 in Journal of Thoracic Disease
Verified
Journal Article
Open access
PDF file
ZYZihan Yi
Zihan Yi
JLJiahao Liu
Jiahao Liu
LSLanying Shen
Lanying Shen
YHYue Hu
Yue Hu
Acute lung injury (ALI) poses a significant clinical challenge due to its high morbidity and mortality rates. Current treatment options are limited in their efficacy, necessitating the exploration of novel therapeutic targets. The mammalian target of rapamycin (mTOR), a crucial regulator of various cellular processes, has been implicated in the pathogenesis of ALI. Autophagy, a tightly regulated cellular degradation process controlled by mTOR, plays a pivotal role in the pathogenesis of ALI and cellular homeostasis. Mounting evidence also suggests that the mTOR pathway and autophagy play crucial roles in the pathogenesis and regulation of ALI. Herein, we reviewed the current understanding of how mTOR signaling and autophagy intersect in the context of ALI, with a focus on their roles across different cell types. This analysis highlights their dual roles in either promoting pulmonary injury or providing protection, depending on the specific cell types and different ALI models. Insights into the intricate balance between mTOR-mediated pathways and autophagic responses provide a foundation for developing targeted therapeutic strategies aimed at alleviating ALI through the modulation of these pathways. This review underscores the therapeutic potential of targeting mTOR and autophagy, presenting innovative and promising approaches for improving the clinical management and outcomes of ALI.

12 June 2025 in International Journal of Medical Sciences
Verified
Journal Article
Open access
PDF file
JLJiahao Liu
Jiahao Liu
ZYZihan Yi
Zihan Yi
TCTing Chen
Ting Chen
YYYinghua Ying
Yinghua Ying
YHYue Hu
Yue Hu
Idiopathic pulmonary fibrosis (IPF), a chronic progressive fibrosing interstitial lung disease with an unclear etiology, is characterized by progressive respiratory impairment and a median survival of 3-5 years. The pathophysiology associated with genetic factors in IPF remains largely unknown, despite the fact that both familial and sporadic IPF exhibit genetic susceptibility. In this review, we comprehensively examine genetic variations associated with the functional roles of mucin 5B (MUC5B), telomerase complex, surfactant proteins, cytokines, signaling pathways, and epigenetic mechanisms. A multifaceted perspective derived from genetic, epidemiological, and clinical studies demonstrates that genetic variations exert differential impacts on the development, progression, and prognosis of IPF. We advocate for the application of genetic knowledge to facilitate the refinement of diagnostic approaches, enhance the assessment of therapeutic strategies and prognostic outcomes, and underscore the significance of personalized therapy for IPF.